Become a UC Advocate
How a plant virus could help stop cancers from reaching the lungs
September 23, 2021
A virus that grows in black-eyed pea plants could form the basis for a new therapy to treat metastatic cancers and established tumors.
California faces short-term nursing shortage from COVID-19 retirements
September 23, 2021
Many older registered nurses have left the field and a large number plan on retiring or quitting within the next two years.
Why is it taking so long to approve a COVID-19 vaccine for kids?
September 23, 2021
UC Riverside vaccine expert David Lo explains the reasons behind the wait.
The Kidney Project successfully tests a prototype bioartificial kidney
September 16, 2021
Taking another big step toward becoming reality, Shuvo Roy's project is awarded KidneyX’s Artificial Kidney Prize.
Sucrose and high fructose corn syrup both linked to increased health risk
September 2, 2021
Sucrose, a more 'natural' form of sugar, may be just as bad for your health.
Second breath: Region’s first double lung transplant for COVID-19 patient
August 26, 2021
Facing a ventilator-bound future, Federico Gomez Gil can finally breathe freely again, thanks to the help of a UC San Diego Health team.
Can this controversial new drug curb Alzheimer’s disease?
August 19, 2021
It’s complicated, but for some patients, there’s reason to be optimistic about aducanumab, the treatment that made waves upon receiving FDA approval this summer.
Q&A: What is realistic when it comes to herd immunity?
August 13, 2021
When will we get back to normal? Dr. Chip Schooley, a national leader in getting students successfully back to campus, offers some insight.
A new treatment for alcohol abuse
August 5, 2021
Researchers have devised a dual-drug therapy for alcohol use disorder (AUD), without the side effects or complications associated with current treatment regimens.
Text-message ‘nudges’ can encourage holdouts to get COVID vaccination, study finds
August 5, 2021
The researchers said their findings held true across all demographics, including groups that have been hesitant to receive the vaccine.